Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz K, Merchant K, Mollenhauer B, Montine TJ, Nudelman K, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tolosa E, Siderowf A, Dunn B, Simuni T, Marek K; Parkinson’s Progression Markers Initiative. Dam T, et al. NPJ Parkinsons Dis. 2024 Sep 27;10(1):178. doi: 10.1038/s41531-024-00789-w. NPJ Parkinsons Dis. 2024. PMID: 39333167 Free PMC article.
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months.
Adams JL, Kangarloo T, Gong Y, Khachadourian V, Tracey B, Volfson D, Latzman RD, Cosman J, Edgerton J, Anderson D, Best A, Kostrzebski MA, Auinger P, Wilmot P, Pohlson Y, Jensen-Roberts S, Müller MLTM, Stephenson D, Dorsey ER; Parkinson Study Group Watch-PD Study Investigators and Collaborators. Adams JL, et al. NPJ Parkinsons Dis. 2024 Jun 12;10(1):112. doi: 10.1038/s41531-024-00721-2. NPJ Parkinsons Dis. 2024. PMID: 38866793 Free PMC article.
Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.
Quattrone A, Franzmeier N, Huppertz HJ, Klietz M, Roemer SN, Boxer AL, Levin J, Höglinger GU; AL‐108‐231 Investigators, the Tauros MRI Investigators, the PASSPORT Study Group, the DESCRIBE‐PSP Group. Quattrone A, et al. Mov Disord. 2024 Aug;39(8):1329-1342. doi: 10.1002/mds.29866. Epub 2024 Jun 2. Mov Disord. 2024. PMID: 38825840
Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease.
Safarpour D, Stover N, Shprecher DR, Hamedani AG, Pfeiffer RF, Parkman HP, Quigley EM, Cloud LJ; Other Non-motor Features Working Group of the Parkinson Study Group. Safarpour D, et al. Among authors: shprecher dr. Parkinsonism Relat Disord. 2024 Jul;124:106982. doi: 10.1016/j.parkreldis.2024.106982. Epub 2024 May 3. Parkinsonism Relat Disord. 2024. PMID: 38729797 Free article. Review.
Conjugal Synucleinopathies: A Clinicopathologic Study.
Adler CH, Halverson M, Zhang N, Shill HA, Driver-Dunckley E, Mehta SH, Atri A, Caviness JN, Serrano GE, Shprecher DR, Belden CM, Sabbagh MN, Long K, Beach TG. Adler CH, et al. Among authors: shprecher dr. Mov Disord. 2024 Jul;39(7):1212-1217. doi: 10.1002/mds.29783. Epub 2024 Apr 10. Mov Disord. 2024. PMID: 38597193
Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium.
Choudhury P, Lee-Iannotti JK, Busicescu AO, Rangan P, Fantini ML, Avidan AY, Bliwise DL, Criswell SR, During EH, Elliott JE, Fields JA, Gagnon JF, Howell MJ, Huddleston DE, McLeland J, Mignot E, Miglis MG, Lim MM, Pelletier A, Schenck CH, Shprecher D, St Louis EK, Videnovic A, Ju YS, Boeve BF, Postuma R; as the NAPS Consortium. Choudhury P, et al. Among authors: shprecher d. Neurology. 2024 Feb 13;102(3):e208008. doi: 10.1212/WNL.0000000000208008. Epub 2024 Jan 5. Neurology. 2024. PMID: 38181331
Comorbid neurotrauma increases neurodegenerative-relevant cognitive, motor, and autonomic dysfunction in patients with rapid eye movement sleep behavior disorder: a substudy of the North American Prodromal Synucleinopathy Consortium.
Elliott JE, Ligman BR, Bryant-Ekstrand MD, Keil AT, Powers K, Olivo C, Neilson LE, Postuma RB, Pelletier A, Gagnon JF, Gan-Or Z, Yu E, Liu L, St Louis EK, Forsberg LK, Fields JA, Ross OA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS, Lim MM; North American Prodromal Synucleinopathy (NAPS) Consortium. Elliott JE, et al. Among authors: shprecher dr. Sleep. 2024 Jun 13;47(6):zsae007. doi: 10.1093/sleep/zsae007. Sleep. 2024. PMID: 38181205 Free PMC article.
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
McGarry A, Rosanbalm S, Leinonen M, Olanow CW, To D, Bell A, Lee D, Chang J, Dubow J, Dhall R, Burdick D, Parashos S, Feuerstein J, Quinn J, Pahwa R, Afshari M, Ramirez-Zamora A, Chou K, Tarakad A, Luca C, Klos K, Bordelon Y, St Hiliare MH, Shprecher D, Lee S, Dawson TM, Roschke V, Kieburtz K. McGarry A, et al. Among authors: shprecher d. Lancet Neurol. 2024 Jan;23(1):37-45. doi: 10.1016/S1474-4422(23)00378-2. Lancet Neurol. 2024. PMID: 38101901 Clinical Trial.
Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.
Choudhury P, Zhang N, Adler CH, Chen K, Belden C, Driver-Dunckley E, Mehta SH, Shprecher DR, Serrano GE, Shill HA, Beach TG, Atri A. Choudhury P, et al. Among authors: shprecher dr. Alzheimers Dement. 2023 Oct;19(10):4377-4387. doi: 10.1002/alz.13357. Epub 2023 Jul 8. Alzheimers Dement. 2023. PMID: 37422286 Free PMC article.
84 results